Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thai Q Tran

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Cellular and Molecular Life Sciences : CMLS|April 12, 2021
Pitx genes in development and diseaseThai Q Tran, Chrissa Kioussi
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2017
Molecular Pathways: Metabolic Control of Histone Methylation and Gene Expression in CancerThai Q Tran, Xazmin H Lowman, Mei Kong
Oncogenesis|November 28, 2018
IKKβ activates p53 to promote cancer cell adaptation to glutamine deprivationMari B Ishak Gabra, Ying Yang, Xazmin H Lowman, et al.
Cell Reports|March 14, 2019
p53 Promotes Cancer Cell Adaptation to Glutamine Deprivation by Upregulating Slc7a3 to Increase Arginine UptakeXazmin H Lowman, Eric A Hanse, Ying Yang, et al.
Plos One|December 31, 2015
TIPRL Inhibits Protein Phosphatase 4 Activity and Promotes H2AX Phosphorylation in the DNA Damage ResponseKimberly Romero Rosales, Michael A Reid, Ying Yang, et al.
Plos Biology|November 7, 2017
Glutamine deficiency induces DNA alkylation damage and sensitizes cancer cells to alkylating agents through inhibition of ALKBH enzymesThai Q Tran, Mari B Ishak Gabra, Xazmin H Lowman, et al.
Genes & Development|September 3, 2016
IKKβ promotes metabolic adaptation to glutamine deprivation via phosphorylation and inhibition of PFKFB3Michael A Reid, Xazmin H Lowman, Min Pan, et al.
Frontiers in Pharmacology|May 7, 2021
Xanthohumol ameliorates Diet-Induced Liver Dysfunction via Farnesoid X Receptor-Dependent and Independent SignalingInes L Paraiso, Thai Q Tran, Armando Alcazar Magana, et al.
Molecular Therapy. Oncology|May 15, 2024
Oncolytic virus V937 in combination with PD-1 blockade therapy to target immunologically quiescent liver and colorectal cancerThai Q Tran, Jeff Grein, Mohammed Selman, et al.
EMBO Reports|July 7, 2021
The B56α subunit of PP2A is necessary for mesenchymal stem cell commitment to adipocyteEric A Hanse, Min Pan, Wenzhu Liu, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Cellular and Molecular Life Sciences : CMLS|April 12, 2021
Pitx genes in development and diseaseThai Q Tran, Chrissa Kioussi
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2017
Molecular Pathways: Metabolic Control of Histone Methylation and Gene Expression in CancerThai Q Tran, Xazmin H Lowman, Mei Kong
Oncogenesis|November 28, 2018
IKKβ activates p53 to promote cancer cell adaptation to glutamine deprivationMari B Ishak Gabra, Ying Yang, Xazmin H Lowman, et al.
Cell Reports|March 14, 2019
p53 Promotes Cancer Cell Adaptation to Glutamine Deprivation by Upregulating Slc7a3 to Increase Arginine UptakeXazmin H Lowman, Eric A Hanse, Ying Yang, et al.
Plos One|December 31, 2015
TIPRL Inhibits Protein Phosphatase 4 Activity and Promotes H2AX Phosphorylation in the DNA Damage ResponseKimberly Romero Rosales, Michael A Reid, Ying Yang, et al.
Plos Biology|November 7, 2017
Glutamine deficiency induces DNA alkylation damage and sensitizes cancer cells to alkylating agents through inhibition of ALKBH enzymesThai Q Tran, Mari B Ishak Gabra, Xazmin H Lowman, et al.
Genes & Development|September 3, 2016
IKKβ promotes metabolic adaptation to glutamine deprivation via phosphorylation and inhibition of PFKFB3Michael A Reid, Xazmin H Lowman, Min Pan, et al.
Frontiers in Pharmacology|May 7, 2021
Xanthohumol ameliorates Diet-Induced Liver Dysfunction via Farnesoid X Receptor-Dependent and Independent SignalingInes L Paraiso, Thai Q Tran, Armando Alcazar Magana, et al.
Molecular Therapy. Oncology|May 15, 2024
Oncolytic virus V937 in combination with PD-1 blockade therapy to target immunologically quiescent liver and colorectal cancerThai Q Tran, Jeff Grein, Mohammed Selman, et al.
EMBO Reports|July 7, 2021
The B56α subunit of PP2A is necessary for mesenchymal stem cell commitment to adipocyteEric A Hanse, Min Pan, Wenzhu Liu, et al.
Pageof 2